Valuation Jiangsu Hengrui Pharmaceuticals Co.,Ltd

Equities

End-of-day quote Shanghai S.E. Other stock markets 2026-01-16			5-day change	1st Jan Change
61.94 ^CNY	-1.95%		-2.61%	+3.98%

Jan. 12	Hengrui Pharma Unit Secures Approval to Conduct Clinical Trial for Hypertension Drug	MT
Jan. 12	Hengrui Pharma's Cancer Drug Obtains China Breakthrough Therapy Designation	MT

Data adjusted to current consolidation scope

Fiscal Period: December	2020	2021	2022	2023	2024	2025	2026	2027
Capitalization ¹	591,745	323,076	245,741	287,598	291,858	412,145	412,145	-
Change	-	-45.4%	-23.94%	17.03%	1.48%	41.21%	0%	-
Enterprise Value (EV) ¹	580,941	309,445	231,891	266,852	267,083	373,329	366,506	358,521
Change	-	-46.73%	-25.06%	15.08%	0.09%	39.78%	-1.83%	-2.18%
P/E ratio	93.7x	71.4x	63.2x	66.5x	45.9x	46.4x	42.3x	34.9x
PBR	19.5x	9.27x	6.5x	7.13x	6.43x	6.83x	6.03x	5.3x
PEG	-	-2.5x	-4.5x	5.8x	1x	1.4x	4.32x	1.6x
Capitalization / Revenue	21.3x	12.5x	11.6x	12.6x	10.4x	12.5x	11.2x	9.6x
EV / Revenue	20.9x	11.9x	10.9x	11.7x	9.54x	11.3x	9.93x	8.35x
EV / EBITDA	77.6x	63.6x	49.2x	47.1x	32.1x	37.1x	33.1x	26.8x
EV / EBIT	82.9x	66.3x	56.4x	54.3x	35.7x	39x	34.2x	27.5x
EV / FCF	202x	120x	-328x	43.2x	48.8x	52x	40.1x	32.6x
FCF Yield	0.5%	0.83%	-0.3%	2.32%	2.05%	1.92%	2.5%	3.07%
Dividend per Share ²	0.1667	0.16	0.16	0.2	0.2	0.2766	0.3157	0.373
Rate of return	0.18%	0.32%	0.42%	0.44%	0.44%	0.45%	0.51%	0.6%
EPS ²	0.9917	0.71	0.61	0.68	1	1.335	1.465	1.775
Distribution rate	16.8%	22.5%	26.2%	29.4%	20%	20.7%	21.5%	21%
Net sales ¹	27,735	25,906	21,275	22,820	27,985	33,098	36,915	42,932
EBITDA ¹	7,483	4,868	4,717	5,666	8,308	10,058	11,073	13,360
EBIT ¹	7,007	4,665	4,112	4,910	7,491	9,563	10,703	13,027
Net income ¹	6,328	4,530	3,906	4,302	6,337	8,757	9,720	11,725
Net Debt ¹	-10,805	-13,631	-13,850	-20,746	-24,775	-38,816	-45,639	-53,624
Reference price ²	92.88	50.71	38.53	45.23	45.90	61.94	61.94	61.94
Nbr of stocks (in thousands)	6,370,846	6,371,045	6,377,915	6,358,560	6,358,560	6,624,271	6,624,271	-
Announcement Date	4/19/21	4/22/22	4/21/23	4/17/24	3/30/25	-	-	-

¹CNY in Million²CNY

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (Y)	EV / Sales (Y)	EV / EBITDA (Y)	Dividend Yield (Y)	Capi.($)
JIANGSU HENGRUI PHARMACEUTICALS CO.,LTD	47.33x	11.52x	37.91x	0.44%	60.31B
ELI LILLY AND COMPANY	45.13x	14.96x	33.19x	0.57%	925B
JOHNSON & JOHNSON	21.43x	5.91x	16.43x	2.35%	529B
ABBVIE INC.	73.45x	7.21x	17.29x	3.02%	383B
ROCHE HOLDING AG	20.1x	5.04x	12.53x	2.86%	368B
ASTRAZENECA PLC	28.37x	5.33x	15.82x	1.72%	291B
NOVARTIS AG	19.99x	5.29x	12.38x	2.87%	274B
MERCK & CO., INC.	14.21x	4.66x	10.01x	2.91%	275B
NOVO NORDISK A/S	15.82x	5.62x	11.6x	3.19%	252B
AMGEN INC.	25.81x	6.12x	10.48x	2.9%	178B
Average	31.17x	7.17x	17.76x	2.28%	353.5B
Weighted average by Cap.	33.29x	8.22x	19.36x	2.1%